Related Experiment Video

Updated: Mar 18, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Cardioprotection by Phytochemicals via Antiplatelet Effects and Metabolism Modulations

Pei-Ying Zhang1

  • 1Department of Cardiology, Xuzhou Central Hospital, No. 199 South Jiefang Road, Xuzhou, 221009, Jiangsu, China. contribution026@163.com.

Cell Biochemistry and Biophysics
|June 29, 2016
PubMed

Insights

Phytochemicals offer cardioprotective benefits by inhibiting platelet activation, a key factor in atherosclerosis and plaque formation. This review explores their antiplatelet effects and beneficial metabolic modifications for heart health.

Area of Science:

  • Cardiovascular Science
  • Pharmacology
  • Biochemistry

Background:

  • Cardiac disorders often stem from multiple factors.
  • Platelet function is a recognized risk factor for atherosclerosis.
  • Activated platelets contribute to chronic inflammation and early plaque formation.

Purpose of the Study:

  • To review the cardioprotective effects of phytochemicals.
  • To highlight the antiplatelet mechanisms of phytochemicals.
  • To discuss metabolic modifications beneficial in cardiac pathology.

Main Methods:

  • Literature review of scientific research.
  • Analysis of phytochemicals' antiplatelet activity.
  • Examination of metabolic pathways in cardiac health.

Main Results:

  • Phytochemicals exhibit significant antiplatelet effects.
  • These effects contribute to a cardioprotective role.
  • Metabolic modifications also demonstrate protective potential.

Conclusions:

  • Phytochemicals represent a promising avenue for preventing cardiovascular disease.
  • Targeting platelet function is crucial for managing atherosclerosis.
  • Further research into phytochemicals and metabolic interventions is warranted.

Keywords:
Antiplatelet effectsCardioprotectionCurcuminMetabolism modulationPhenolicsPhytochemicalPolyphenolsResveratrol

More Related Videos

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.3K
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

1.3K

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
512
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813